# U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc. is a company headquartered in Sunrise, FL, United States.

## Company overview

- **Legal name:** U.S. Stem Cell, Inc.
- **Former names in filing history:** BIOHEART, INC. (2007-02-13 to 2015-11-02)
- **Classification:** Company
- **Industry (SIC):** 8731 — Services-Commercial Physical & Biological Research
- **Headquarters:** Sunrise, FL, United States
- **Incorporated in:** FL
- **Fiscal year end:** December 31
- **SEC CIK:** 0001388319

## About

U.S. Stem Cell, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001388319, and its reported industry is Services-Commercial Physical & Biological Research. In 10-K filed on 2023-04-14, it reported annual revenue of USD 82,049; net income of USD -2,857,943; total assets of USD 68,039 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $82,049 (USD 82,049)
- **Net income:** -$2.9M (USD -2,857,943)
- **Total assets:** $68,039 (USD 68,039)
- **Cash and equivalents:** $5,133 (USD 5,133)
- **Operating cash flow:** -$304,852 (USD -304,852)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $200,749 (USD 200,749)
- **Net income:** -$3.3M (USD -3,287,416)
- **Total assets:** $50,999 (USD 50,999)
- **Cash and equivalents:** $39,393 (USD 39,393)
- **Operating cash flow:** -$1.1M (USD -1,057,939)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $277,087 (USD 277,087)
- **Net income:** -$2.9M (USD -2,890,493)
- **Total assets:** $88,152 (USD 88,152)
- **Cash and equivalents:** $18,570 (USD 18,570)
- **Operating cash flow:** -$478,886 (USD -478,886)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $3.1M (USD 3,072,293)
- **Net income:** -$3.8M (USD -3,835,337)
- **Total assets:** $89,843 (USD 89,843)
- **Cash and equivalents:** $0 (USD 0)
- **Operating cash flow:** -$1.2M (USD -1,210,994)

## Recent SEC filings

- Form 10-K — filed 2023-04-14 — period 2022-12-31 — FORM 10-K
- Form 10-Q — filed 2022-11-09 — period 2022-09-30 — FORM 10-Q
- Form 10-Q — filed 2022-08-22 — period 2022-06-30 — FORM 10-Q
- Form 10-K/A — filed 2022-07-08 — period 2021-12-31 — FORM 10-K/A
- Form 10-Q — filed 2022-05-23 — period 2022-03-31 — FORM 10-Q
- Form 10-K — filed 2022-03-31 — period 2021-12-31 — FORM 10-K
- Form 8-K — filed 2022-03-09 — period 2022-03-04 — FORM 8-K
- Form 10-Q — filed 2021-11-09 — period 2021-09-30 — FORM 10-Q
- Form 10-Q — filed 2021-08-12 — period 2021-06-30 — FORM 10-Q
- Form 10-Q — filed 2021-07-16 — period 2021-03-31 — FORM 10-Q
- Form 10-K — filed 2021-07-16 — period 2020-12-31 — FORM 10-K
- Form 10-Q — filed 2021-07-16 — period 2020-09-30 — FORM 10-Q

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/u-s-stem-cell-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology